Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury [1]
A review that may affect pharma strategy in the immediate future.
A review that may affect pharma strategy in the immediate future.
Links
[1] https://spb-cts.freelock.com/jans/combined-antiplateletanticoagulant-drug-cardiac-ischemiareperfusion-injury
[2] https://spb-cts.freelock.com/home/aprotopapas
[3] https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.120.317450
[4] https://spb-cts.freelock.com/taxonomy/molecular-biology
[5] https://spb-cts.freelock.com/taxonomy/pharmacology
[6] https://spb-cts.freelock.com/taxonomy/physiology
[7] https://spb-cts.freelock.com/tags/cardiac-pharmacology
[8] https://spb-cts.freelock.com/tags/cardiac-physiology
[9] https://spb-cts.freelock.com/taxonomy/intensive-care
[10] https://spb-cts.freelock.com/taxonomy/intensive-care-guidelines
[11] https://spb-cts.freelock.com/tags/pharmacology
[12] https://spb-cts.freelock.com/tags/physiology
[13] https://spb-cts.freelock.com/categories/cardiac
[14] https://spb-cts.freelock.com/taxonomy2018/coronary-disease
[15] https://spb-cts.freelock.com/taxonomy2018/endovascular